Find out what we do


Blog


Is there a gene for genius?

at Monday, May 20, 2013

In a shabby compound in Shenzhen, Southern China, a team of scientists from the Beijing Genomics Institute are trying to decode the genes that make people intelligent, as documented in the Times and Wall Street Journal.

Led by school dropout, turned prodigal genetic engineer Zhao Bowen, the state-funded institute has samples of DNA from 2,000 certified geniuses and is trying to deduce what sets them apart, at a genetic level, from the proletariat. It's also sequencing DNA from plants and animals at a terrific rate: six terabytes of data per day. 

In the time it takes to read this blog, Bowen's team will have mapped another human genome at a cost of $3,000. Compare this to the first mapping of a human genome ten years ago, which took several years and $3bn, and the rate of progress is staggering.

Bowen's work has attracted controversy but he sees it as simply another brick in the pyramid of knowledge. His view is that science is neither good nor bad; it is simply the process of finding the truth. The good or bad comes from how the science is applied. He confirms that China is not trying to breed geniuses and that the best way to produce bright children is still to have two bright parents. Even if genes that promote high IQ can be identified, there is a huge variety of factors, both genetic, physical, and environmental, that have to align for a child to be exceptionally gifted.

There is a warning in this for all of us in the business of science against making the science sound better than it is to promote a business case. Bowen fears that, based on his research, companies will falsely claim to be able to produce genetically-engineered genius-IQ children to exploit the dreams of aspiring parents. Realistically, the most radical output from the institute might be a test to determine a baby's IQ from the womb in the early stages of pregnancy. Bowen sees this as progress, but it raises ethical concerns. Could we - and more importantly, should we - set an IQ benchmark to determine whether or not a foetus is taken to term?

Will genetic sequencing of babies eventually become the norm? Bowen thinks so. The benefits for identification and treatment of genetic weaknesses or diseases from birth (or before) are clear; but there is a danger in the potential for pre-birth discrimination against a foetus based on its genetic make-up.

Bowen's view is that technology needs to keep advancing for us to progress. He says: "Technology is just something invented after you were born. A wheel is not technology anymore. That doesn't mean it's not important, it just becomes part of our lives. Sequencing will be like the wheel."

Authored by Neil Hardman

Photo credit: Ynse

Permalink

Twitter


Latest News


19 April 2013: Tudor Reilly MD shortlisted for the First Women Awards
Tudor Reilly managing director Julie Walters has been shortlisted for the prestigious First Women Awardsrecognising pioneering UK women in business who have provided opportunities for others.

The judging panel recognised Julie’s remarkable career, from being one of the first female journalists to enter Kuwait with the troops in 1992, to setting up and growing Tudor Reilly from a three-person start-up to a successful healthcare communications consultancy.

Julie’s vision has driven Tudor Reilly’s groundbreaking work building patient-centred online communities for e-patients. Our online communities www.practicalalzheimers.com and www.hepatitiscnews.com, which are among the first of their kind, have thousands of visitors each week, providing e-patients and their carers with help on managing these conditions.

The panel also recognised Julie’s passion for female empowerment in business. She is a member of the International Womens’ Federation and president of the Entrepreneurs’ Organisation in the UK. There is a strong ethos of equality within Tudor Reilly, evidenced by the fact that nine of our fourteen staff, and two of our three directors, are women.

Recognising Julie’s career, Edna Kissmann, former chief executive of Burston Marsteller (UK) says: “Julie Walters has a vision of excellence in the health communications business. Her actions always focused on two factors: getting to the end goal, and ensuring that many join her on the journey - because it is exciting and fulfilling, and because much good happens along the way.”

Julie says: “It’s an honour to be shortlisted for this award alongside some incredibly successful women. The First Women Awards’ recognition of outstanding women in business, especially those who provide opportunities for others, is incredibly important, and I’m delighted to be a part of it.”

..more